광견병 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Rabies Diagnostics Market size is expected to reach USD 4.00 Billion in 2034 from USD 2.70 Billion (2025) growing at a CAGR of 4.44% during 2026-2034.

The Global Rabies Diagnostics Market is growing steadily due to the continued prevalence of rabies in developing regions. Increasing government initiatives aimed at rabies elimination are driving diagnostic testing demand. Early and accurate detection is critical for effective disease management and prevention. The expansion of veterinary healthcare infrastructure is contributing to market growth. Rising awareness campaigns regarding vaccination and testing are increasing screening rates. Technological advancements in molecular diagnostic techniques are improving accuracy. Future prospects are supported by global efforts to achieve zero rabies deaths.

Another significant driver is the increasing adoption of rapid diagnostic kits in rural and remote areas. Point-of-care testing solutions are enhancing accessibility and reducing turnaround time. International health organizations are funding rabies surveillance programs in endemic countries. The growing population of stray animals in certain regions is increasing testing requirements. Research institutions are focusing on developing cost-effective and portable testing devices. Public-private partnerships are strengthening distribution networks. Over the forecast period, advancements in PCR-based and immunoassay technologies will accelerate growth.

The market is also influenced by expanding veterinary diagnostics and laboratory capabilities worldwide. Companion animal healthcare expenditure is rising, boosting routine testing demand. Improved cold chain logistics are supporting distribution of diagnostic reagents. Regulatory agencies are promoting standardized diagnostic protocols to ensure reliability. Increasing collaboration between governments and NGOs is improving disease monitoring systems. Biotechnology companies are investing in innovative assay development. In the long term, integrated surveillance systems and digital reporting platforms will further enhance the rabies diagnostics market outlook.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Diagnostic Method

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests

By Technology Method

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

COMPANIES PROFILED

• BioRad Laboratories Inc, Aviva Systems Biology Corporation, Merck KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics, Norgen Biotek Corp, Abbexa Ltd, Express Biotech International Inc, BioNote Inc, MyBioSourcecom
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RABIES DIAGNOSTICS MARKET: BY DIAGNOSTIC METHOD 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Diagnostic Method
• 4.2. Fluorescent Antibody Test (FAT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunohistochemical Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Amplification Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Histologic Examination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Serology Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RABIES DIAGNOSTICS MARKET: BY TECHNOLOGY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology Method
• 5.2. ELISA/Immunohistochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chromatography Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RABIES DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Diagnostic Method
  • 6.2.2 By Technology Method
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Diagnostic Method
  • 6.3.2 By Technology Method
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Diagnostic Method
  • 6.4.2 By Technology Method
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Diagnostic Method
  • 6.5.2 By Technology Method
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Diagnostic Method
  • 6.6.2 By Technology Method
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RABIES DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Bio-Rad Laboratories Inc
  • 8.2.2 Aviva Systems Biology Corporation
  • 8.2.3 Merck KGaA
  • 8.2.4 Demeditec Diagnostics GmbH
  • 8.2.5 Creative Diagnostics
  • 8.2.6 Norgen Biotek Corp
  • 8.2.7 Abbexa Ltd
  • 8.2.8 Express Biotech International Inc
  • 8.2.9 BioNote Inc
  • 8.2.10 MyBioSource.Com